• Small Molecules
    • Large Molecules
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Peptides

Syngene has considerable experience in peptide development including state-of-the-art analytical instruments for peptide purification and characterization. Our experience in Peptide development is as follows:

  • Linear peptides:  Up to 50 residues, up to g scale, purity > 95%;
  • Disulfide rich peptides (Linear and Cyclotides)
  • Library of 50 compounds (20-50 mg, >95%)
  • Branched Chain peptides
  • Cyclic peptides: Amides, Lactams, Disulfide bridge, Stapled peptides.
  • N-Terminal and C-Terminal modification
  • Phosphorylated peptides
  • PEG, Fluorescein, Biotin labeled peptides
  • Peptides linked to bifunctional chelating agents such as DOTA, DTPA and AAZTA
  • Ligation: NCL and KAHA ligation

To download, Please share your details

To download, Please share your details